Weight gain in epileptic patients during treatment with valproic acid: a retrospective study.
Open Access
- 1 August 1997
- journal article
- clinical trial
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences
- Vol. 24 (3) , 240-244
- https://doi.org/10.1017/s0317167100021879
Abstract
Weight gain has been recognized as a common adverse effect of valproic acid (VPA) that leads to discontinuation in some patients but its incidence and correlates have been rarely studied.Keywords
This publication has 11 references indexed in Scilit:
- Obesity and endocrine disorders in women taking valproate for epilepsyAnnals of Neurology, 1996
- Bodyweight Change as an Adverse Effect of Drug TreatmentDrug Safety, 1996
- A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Valproic AcidDrugs, 1994
- Valproate and palmitate binding to serum albumin in valproate-treated patients. relation to obesityEpilepsy Research, 1993
- A Comparison of Valproate with Carbamazepine for the Treatment of Complex Partial Seizures and Secondarily Generalized Tonic–Clonic Seizures in AdultsNew England Journal of Medicine, 1992
- Metabolic changes during treatment with valproate in humans: Implication for untoward weight gainMetabolism, 1992
- Weight gain during treatment with valproateActa Neurologica Scandinavica, 1984
- Multiple sclerosis, HLA, and lymphocyte surface markersActa Neurologica Scandinavica, 1984
- Effects of sodium valproate in 100 children with special reference to weight.BMJ, 1981